China Beta Cyclodextrin powder Manufacturers, Suppliers, Factory

Xi’an Deli Biochemical Industry Co., Ltd. has officially announced the expansion of its active pharmaceutical ingredient (API) and excipient portfolio with the addition of Glucosamine Sulfate Sodium Chloride (CAS 1296149-13-7). Backed by over 26 years of specialized manufacturing experience, the company aims to provide high-purity ingredients, full technical documentation, and scalable global supply support for joint health formulations and pharmaceutical development. Building on its established leadership in cyclodextrin derivatives—such as Hydroxypropyl Betadex (HPBCD) and Sulfobutyl Ether Beta Cyclodextrin Sodium (SBECD)—Xi’an Deli’s latest release reinforces its strategy to deliver diversified, high-quality solutions for pharmaceutical manufacturers and partners across Europe, Asia, and global markets.

Xi’an DELI Biochemical Industry Co., Ltd. will participate in CPHI Milan 2026 from October 6 to 8 at Fiera Milano, Italy. Visit Booth 1H24 to explore our pharmaceutical excipient portfolio, including Hydroxypropyl Betadex, Betadex Sulfobutyl Ether Sodium, and Beta-Cyclodextrin, together with selected APIs and pharmaceutical raw materials such as Glucosamine Sulfate Sodium Chloride, Menatetrenone, and L-Phenylalanine. Our team looks forward to meeting pharmaceutical companies, CDMOs, distributors, formulation developers, and industry partners to discuss product evaluation, technical documentation, samples, and long-term cooperation.

In the cosmetic industry, Hydroxypropyl betadex is utilized for encapsulating and delivering active ingredients, enhancing their stability and bioavailability. It is also used to improve the solubility and absorption of essential oils and other hydrophobic compounds in skincare products.

cyclodextrins have mainly been used as complexing agents to increase the aqueous solubility of active substances poorly soluble in water, in order to increase their bioavailability and to improve stability.

Recently, Xi'an DELI Biochemical announced new progress in the application of Betadex Sulfobutyl Ether Sodium (SBECD) at its research facility in Xi'an, China. Driven by the growing demand for effective formulation solutions for poorly soluble drugs, the company's scientists optimized inclusion complex technology to enhance drug solubility and stability. The achievement highlights the important role of SBECD in modern drug delivery systems and supports the development of high-quality pharmaceutical products worldwide.

Menatetrenone is gaining increasing attention for those concerned about bone and cardiovascular health. A natural question arises: Can we get the necessary menatetrenone through our daily diet? This directly impacts the need for supplementation, and therefore warrants further investigation.